Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multicentre, Randomized Comparative Study to Evaluate the Efficacy and Safety of Using the Sibutramin-containing Drugs Reduxin® Forte and Reduxin® in Patients With Alimentary Obesity

NCT05821543 is registered in ClinicalTrials.gov with Promomed, LLC as lead sponsor.

NCT NCT05821543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05821543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multicentre, Randomized Comparative Study to Evaluate the Efficacy and Safety of Using the Sibutramin-containing Drugs Reduxin® Forte and Reduxin® in Patients With Alimentary Obesity
Lead sponsor
Promomed, LLC
Phase
Phase 4
Overall status
Completed
Start date
July 3, 2020
Completion date
May 21, 2021
Enrollment
240 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

obesity